Isolation and characterization of intermediates in vaccinia virus morphogenesis.
D000818:Animals; D002250:Carbon Radioisotopes; D002458:Cell Fractionation; D002499:Centrifugation, Density Gradient; D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication; D004279:DNA, Viral / Q000096:biosynthesis / Q000302:isolation & purification; D004591:Electrophoresis, Polyacrylamide Gel; D007739:L Cells; D051379:Mice; D008854:Microscopy, Electron; D009024:Morphogenesis; D009698:Nucleoproteins / Q000032:analysis / Q000302:isolation & purification; D010455:Peptides / Q000032:analysis; D010761:Phosphorus Radioisotopes; D012293:Rifampin / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014616:Vaccinia virus / Q000032:analysis / Q000254:growth & development* / Q000378:metabolism / Q000648:ultrastructure; D014764:Viral Proteins / Q000032:analysis / Q000302:isolation & purification
D002250:Carbon Radioisotopes; D004279:DNA, Viral; D009698:Nucleoproteins; D010455:Peptides; D010761:Phosphorus Radioisotopes; D014764:Viral Proteins; D003561:Cytarabine; D014316:Tritium; D013936:Thymidine; D012293:Rifampin